Company · Healthtech & Bio

Cocoon Bioscience

cocoonbio.com ↗ ·Bilbao ·Series A

Cocoon Bioscience is a Bilbao-area biomanufacturing startup that uses its proprietary CrisBio® insect-based expression platform (moth cocoons as bioreactors) to produce specialty recombinant enzymes and high-performance growth factors at low cost. Spun off in 2022 from Algenex (following Algenex's sale to Insud Pharma), it serves life-science customers (mRNA/IVT synthesis, sequencing enzymes) as well as the alternative-protein/cultivated-meat industry. The company has raised roughly $17.9M across two 2023 rounds from investors including Columbus Venture Partners, Cleon Capital and North South Ventures, and is led by CEO Joshua Robinson.

Founded
2022
Founders
1
News
0
Rounds
2
Investors
6
SectorsBiotechnology, Biomanufacturing, Enzymes, Alternative protein / Cultivated meat Start-up MapHealthtech & Bio › Biologics manufacturing & CDMO

Profile updated 2 Aug 2026

Founders

Joshua Robinson
CEO

Global models

No comparables on record yet.

Investors 6

Cleon Capital
www.cleoncapital.com ↗
Investor Spain
Columbus Venture Partners
columbusvp.com
Investor Spain
Gestión de Capital Riesgo del País Vasco
www.spri.eus/es/capital-riesgo
Investor Spain
MONDRAGON Ventures
mondragon-corporation.com
Investor Spain
North South Ventures
northsouthvc.com ↗
Investor United States
Sangha Capital
www.sanghacapital.co ↗
Investor Switzerland

Funding rounds 2

Series A · €2M
Cocoon Bioscience, which uses cocooned insects as bioreactors to produce enzymes and growth factors for pharma and cultivated meat, raised €…
2023-11-06
Series A · €15M
Cocoon Bioscience, an Algenex spin-out that uses cocooned insects as natural bioreactors to make specialty enzymes and growth factors for mR…
2023-03-14

News & media

No coverage on record yet.
Start typing to search across everything.
↑↓ navigate↵ openesc close